New funding boost for delivery of early stage clinical research across Greater Manchester
NIHR Manchester Clinical Research Facility (MCRF) has received a £15.5 million award, further enabling it to provide opportunities for people of all ages and backgrounds across Greater Manchester to take part in research.
Nationally, the NIHR has announced nearly £161 million to fund 28 NIHR Clinical Research Facilities (CRFs), expanding the delivery of early phase clinical research in NHS hospitals across England.
NIHR CRFs are a key part of the UK’s leading early stage clinical research infrastructure and play an important role in making the country a global hub for life sciences.
They support the delivery of early translational and experimental medicine research, from studies testing new treatments in patients for the very first time (first-in-human trials) through to early safety and efficacy trials (Phase IIa trials). They provide dedicated purpose-built facilities and expertise for the delivery of high-intensity studies funded by the NIHR, the life sciences industry and other organisations.
A total of 28 NIHR CRFs have been awarded funding in this latest round – five more than previously. These CRFs, which will run from 2022 to 2027, will play a key role in realising the ambition in the vision for the future of UK clinical research delivery to bolster the delivery of innovative trials across all phases, all treatment types and all conditions.
NIHR Manchester (MCRF) was founded in 2017 and is hosted by Manchester University NHS Foundation Trust (MFT). This new funding award – A 24 per cent uplift on 2017-2022 – will allow MCRF to further grow its experimental medicine provision across Greater Manchester during the next five years, along with partners at The Christie NHS Foundation Trust and Northern Care Alliance NHS Foundation Trust .
Reference Link: https://www.manchester.ac.uk/discover/news/new-funding-boost-for-delivery-of-early-stage-clinical-research-across-greater-manchester/
Posted By
GSP Admin